Skip to content
healthcare.dev

Liothyronine Sodium

NDC 39822-0151, Liothyronine Sodium, injection, solution, from XGen Pharmaceuticals DJB, Inc..

Product NDC
39822-0151
Status
Listed
Labeler
XGen Pharmaceuticals DJB, Inc.
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA076923
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/39822-0151 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LIOTHYRONINE SODIUM10 ug/mL

Pharmacologic classes

Triiodothyronine [CS]; l-Triiodothyronine [EPC]

Package NDCNDC-11Package
39822-0151-1398220151011 VIAL in 1 CARTON (39822-0151-1) / 1 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a8b39730-de19-497d-bde8-6594aa528403

Use it

Look up 39822-0151 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/39822-0151 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 39822-0151. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.